- Home
- /
- Drugs
- /
- D DERMATOLOGICALS
- /
- D02
- /
- D02A
- /
- D02AX
- /
- Oilatum Plus
Oilatum Plus
Summary of product characteristics
1. Name of the medicinal product
Oilatum Plus
Oilatum Junior Flare-Up
2. Qualitative and quantitative composition
Light liquid paraffin 52.5% w/w, benzalkonium chloride 50% solution 12.0% w/w*, triclosan 2% w/w
*equivalent to 6% benzalkonium chloride
3. Pharmaceutical form
Bath additive
4.1. Therapeutic indications
Topical as a bath additive.
For the prophylactic treatment of eczemas at risk from infection.
4.2. Posology and method of administration
For cutaneous use only.
Oilatum Plus must always be used diluted in water. It is an effective cleanser and should not be used with soap.
Use once daily. Do not exceed the recommended dose:
Adults, adolescents and children:In an eight inch bath (20 cm) add 2 capfuls (20 ml); in a four inch (10 cm) bath add 1 capful (10 ml). Mix well.
Soak for 10-15 minutes. Gently pat the skin dry with a clean towel.
Infants over 6 months of age: Add 1 ml (just sufficient to cover the bottom of the cap) to a baby bath containing approximately 15 litres of water and mix well. Soak for 10-15 minutes. Gently pat the skin dry with a clean towel.
The safety and efficacy of Oilatum Plus has not been established in children less than 6 months of age. Oilatum Plus is not recommended for use in children under 6 months of age.
Elderly: No dosage adjustment is required in the elderly.
4.3. Contraindications
Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1
4.4. Special warnings and precautions for use
Oilatum Plus contains benzalkonium chloride which is irritant and may cause skin reactions.
Keep out of reach and sight of children.
If irritation or rash occurs when the product is used in the correct dilution, use should be discontinued.
If the undiluted product comes into contact with the eye, reddening may occur. The patient should be advised to perform eye irrigation for 15 minutes. If there is persistent irritation the patient should be advised to contact a doctor.
Avoid contact of the undiluted product with the eyes and skin.
If undiluted product is applied directly to the skin, it may cause application site skin irritation and hypersensitivity reactions including skin exfoliation, pain, blister, caustic injury and necrosis. The patient should be advised to contact a doctor.
The patient should be advised to use care to avoid slipping in the bath.
Instruct patients not to smoke or go near naked flames – risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.
4.5. Interaction with other medicinal products and other forms of interaction
None known.
4.6. Fertility, pregnancy and lactation
Fertility
There are no data on the use of Oilatum Plus on human fertility.
Pregnancy
No effects on pregnancy are anticipated, since systemic exposure to Oilatum Plus is expected to be low.
Lactation
It is not known if Oilatum Plus is excreted in human milk. Risk to the infant is likely to be low since systemic exposure is low.
Patients should be advised to ensure that any residual product is fully washed off the breast prior to breast-feeding.
4.7. Effects on ability to drive and use machines
None known.
4.8. Undesirable effects
Adverse drug reactions (ADRs) are listed below by MedDRA system organ class and by frequency. Frequencies are defined as not known (cannot be estimated from the available data).
Post-marketing data
Skin and subcutaneous tissues disorders
Not Known: Application site reactions including- skin exfoliation, erythema, dermatitis, pruritus and burning sensation.
Immune System disorders
Not known: Application site hypersensitivity
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at:www.mhra.gov.uk/yellowcard.
4.9. Overdose
Oilatum Plus is intended for cutaneous use only. Accidental ingestion may cause gastrointestinal irritation with nausea, vomiting and diarrhoea. It may also cause oesophageal erosion and necrosis.
Oilatum Plus is unlikely to have any systemic effects. Using more frequently than recommended may cause skin irritation and rash (see 4.8 Undesirable effects).In case of accidental ingestion, management should be as clinically indicated or as recommended by the national poisons centre, where available.
5.1. Pharmacodynamic properties
ATC Code
Pharmacotherapeutic Group: Dermatologicals, other emollients and protectives
ATC code: D02AX
Light liquid paraffin is an emollient widely used in the treatment of eczema. Benzalkonium chloride is a quaternary ammonium antiseptic and disinfectant.
Triclosan is a chlorinated bisphenol antiseptic.
Benzalkonium chloride is bactericidal against Gram-positive and, at higher concentrations, against some Gram-negative organisms.
Triclosan is effective against Gram-positive and most Gram-negative bacteria.
Both benzalkonium chloride and triclosan have proven efficacy against Stapylococcus aureus, the principal causative organism in infected eczemas.
5.2. Pharmacokinetic properties
There have been no studies to investigate the pharmacokinetics of light liquid paraffin, benzalkonium chloride or triclosan when administered as Oilatum Plus. However, studies of benzalkonium chloride alone and triclosan alone showed minimal absorption. Light liquid paraffin is chemically and biologically inert.
The potential for systemic absorption of Oilatum Plus from a bath additive containing 52.5% w/w light liquid paraffin, 6% w/w benzalkonium chloride and 2.0% w/w of triclosan is expected to be low.
5.3. Preclinical safety data
Benzalkonium chloride
Skin irritation and ocular irritation were noted when benzalkonium chloride was tested at concentrations greater than 0.1%. Benzalkonium chloride was not mutagenic in bacterial assays but was clastogenic in some in vitro mammalian assays. There was no evidence of carcinogenicity in lifetime dermal testing in mice and rabbits.
Triclosan
Triclosan is not reported to be genotoxic in bacterial and mammalian test systems.
Reproduction
There are no data on the effect of cutaneous application of light liquid paraffin, benzalkonium chloride, triclosan on embryo-fetal development or fertility.
6.1. List of excipients
Acetylated lanolin alcohols
Isopropyl palmitate
Oleyl alcohol
Polyoxyethylene lauryl ether
6.2. Incompatibilities
Benzalkonium chloride solution is inactivated by inorganic compounds including soaps and must not be mixed with other anionic surfactants.
6.3. Shelf life
a) For the product as packaged for sale
3 years
b) After first opening the container
Comply with expiry date
6.4. Special precautions for storage
None.
6.5. Nature and contents of container
White polyvinyl chloride or high density polyethylene bottles containing 20ml, 25ml, 150ml, 250ml, 350ml, 500ml, 600ml, 1000ml with white polypropylene cap.
6.6. Special precautions for disposal and other handling
There are no special instructions for use or handling of Oilatum Plus/Oilatum Junior Flare-Up
7. Marketing authorisation holder
Thornton & Ross Ltd.
Linthwaite,
Huddersfield,
HD7 5QH, UK
8. Marketing authorisation number(s)
PL 00240/0462
9. Date of first authorisation/renewal of the authorisation
16/02/1990
10. Date of revision of the text
08/11/2019
4.1 Therapeutic indications
Topical as a bath additive.
For the prophylactic treatment of eczemas at risk from infection.
4.2 Posology and method of administration
For cutaneous use only.
Oilatum Plus must always be used diluted in water. It is an effective cleanser and should not be used with soap.
Use once daily. Do not exceed the recommended dose:
Adults, adolescents and children:In an eight inch bath (20 cm) add 2 capfuls (20 ml); in a four inch (10 cm) bath add 1 capful (10 ml). Mix well.
Soak for 10-15 minutes. Gently pat the skin dry with a clean towel.
Infants over 6 months of age: Add 1 ml (just sufficient to cover the bottom of the cap) to a baby bath containing approximately 15 litres of water and mix well. Soak for 10-15 minutes. Gently pat the skin dry with a clean towel.
The safety and efficacy of Oilatum Plus has not been established in children less than 6 months of age. Oilatum Plus is not recommended for use in children under 6 months of age.
Elderly: No dosage adjustment is required in the elderly.
4.3 Contraindications
Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1
4.4 Special warnings and precautions for use
Oilatum Plus contains benzalkonium chloride which is irritant and may cause skin reactions.
Keep out of reach and sight of children.
If irritation or rash occurs when the product is used in the correct dilution, use should be discontinued.
If the undiluted product comes into contact with the eye, reddening may occur. The patient should be advised to perform eye irrigation for 15 minutes. If there is persistent irritation the patient should be advised to contact a doctor.
Avoid contact of the undiluted product with the eyes and skin.
If undiluted product is applied directly to the skin, it may cause application site skin irritation and hypersensitivity reactions including skin exfoliation, pain, blister, caustic injury and necrosis. The patient should be advised to contact a doctor.
The patient should be advised to use care to avoid slipping in the bath.
Instruct patients not to smoke or go near naked flames – risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.
4.5 Interaction with other medicinal products and other forms of interaction
None known.
4.6 Fertility, pregnancy and lactation
Fertility
There are no data on the use of Oilatum Plus on human fertility.
Pregnancy
No effects on pregnancy are anticipated, since systemic exposure to Oilatum Plus is expected to be low.
Lactation
It is not known if Oilatum Plus is excreted in human milk. Risk to the infant is likely to be low since systemic exposure is low.
Patients should be advised to ensure that any residual product is fully washed off the breast prior to breast-feeding.
4.7 Effects on ability to drive and use machines
None known.
4.8 Undesirable effects
Adverse drug reactions (ADRs) are listed below by MedDRA system organ class and by frequency. Frequencies are defined as not known (cannot be estimated from the available data).
Post-marketing data
Skin and subcutaneous tissues disorders
Not Known: Application site reactions including- skin exfoliation, erythema, dermatitis, pruritus and burning sensation.
Immune System disorders
Not known: Application site hypersensitivity
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at:www.mhra.gov.uk/yellowcard.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).